Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Juliette Abeillon-du Payrat"'
Autor:
Victor Vermot-Desroches, Kim Thia-Soui-Tchong, Perrine Raymond, Andrea Filip, Jacques Orgiazzi, Emmanuel Jouanneau, Caroline Froment Tilikete, Françoise Borson-Chazot, Romain Manet, Juliette Abeillon Du Payrat
Publikováno v:
Annales d'Endocrinologie.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5a1d0ee1343d93133b00153dd0e8ae2
https://doi.org/10.1016/j.ando.2023.04.002
https://doi.org/10.1016/j.ando.2023.04.002
Autor:
Rachel Fourneaux, Sarah Castets, Alice Godefroy, Maude Grelet, Juliette Abeillon-du Payrat, Alexandru Saveanu, Frederic Castinetti, Rachel Reynaud
Publikováno v:
Hormone Research in Paediatrics
Hormone Research in Paediatrics, 2022, 95 (3), pp.296-303. ⟨10.1159/000524233⟩
Hormone Research in Paediatrics, 2022, 95 (3), pp.296-303. ⟨10.1159/000524233⟩
Introduction: Congenital central hypothyroidism (CCH) is a rare disorder that can be caused by X-linked mutations in the immunoglobulin superfamily member 1 (IGSF1) gene. Here, we describe four familial cases with a variable presentation due to a nov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::902b9777b6a137323c37ccdc20e5addb
https://hal-amu.archives-ouvertes.fr/hal-04034050
https://hal-amu.archives-ouvertes.fr/hal-04034050
Autor:
Juliette Abeillon-du Payrat, Georges Kaltenbach, Véronique Raverot, Lionel Groussin, Anne Cailleux, Pierre Wolff, Bernard Goichot, Olivier Lairez, Remy Leroy, Marc Klein, Philippe Caron, Lavinia Vija Racaru
Publikováno v:
Annales d'Endocrinologie. 81:511-515
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6449ec49fe72f0eb5fdf8ff68ed4354
https://doi.org/10.1016/j.ando.2020.05.002
https://doi.org/10.1016/j.ando.2020.05.002
Autor:
Lionel Groussin, Remy Leroy, Marc Klein, Philippe Caron, Georges Kaltenbach, Véronique Raverot, Olivier Lairez, Juliette Abeillon–Du Payrat, Anne Cailleux, Bernard Goichot, Pierre Wolff, Lavinia Vija Racaru
Publikováno v:
Annales d'Endocrinologie. 81:89-100
Annales d'Endocrinologie - In Press. Accepted Manuscript Available online since lundi 4 mai 2020
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9522a58a930f0e45007ea049b2c5f21a
https://doi.org/10.1016/j.ando.2020.04.010
https://doi.org/10.1016/j.ando.2020.04.010
Autor:
Gilles Zah-Bi, Juliette Abeillon-du Payrat, Anne Laure Vie, Moncef Berhouma, Claire Bournaud-Salinas, Emmanuel Jouanneau
Publikováno v:
Neurosurgery. 85:E1059-E1067
BACKGROUND Dysthyroid optic neuropathy (DON) is a devastating complication of thyroid eye disease. Corticosteroids are the primary medical treatment for DON, but some refractory patients may require surgical management. OBJECTIVE To evaluate the effi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32f39af2e72cfdc8d49f1a9697f1cc85
https://doi.org/10.1093/neuros/nyz268
https://doi.org/10.1093/neuros/nyz268
Autor:
Juliette Abeillon du Payrat, Françoise Borson-Chazot, Christine Cugnet-Anceau, Emmanuel Disse, Denis Maillet, Manon Levy, Gerald Raverot
Publikováno v:
Bulletin du Cancer
Bulletin du Cancer, 2020, 107 (4), pp.490--498. ⟨10.1016/j.bulcan.2020.01.012⟩
Bulletin du Cancer, 2020, 107 (4), pp.490--498. ⟨10.1016/j.bulcan.2020.01.012⟩
Resume Les indications des inhibiteurs de checkpoint (ICP) immunitaire sont maintenant tres etendues et ont fait emerger des complications endocriniennes specifiques avec lesquelles les oncologues ont du se familiariser. L’hypophysite en est un exe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7cabb601d6f3321c12997787143bc23
https://hal.science/hal-02901888/file/S0007455120301168.pdf
https://hal.science/hal-02901888/file/S0007455120301168.pdf
Autor:
Juliette Abeillon, du Payrat, Christine, Cugnet-Anceau, Denis, Maillet, Manon, Levy, Gérald, Raverot, Emmanuel, Disse, Françoise, Borson-Chazot
Publikováno v:
Bulletin du cancer. 107(4)
Checkpoint inhibitors immunotherapy is more and more prescribed in oncology, causing new immune related endocrine adverse events. Hypophysitis occurs in approximately 10 % of patients treated with anti-CTLA4. It occurs two to three months after initi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e383f50a023ee5c0b1a44fcd1a34da12
https://pubmed.ncbi.nlm.nih.gov/32200950
https://pubmed.ncbi.nlm.nih.gov/32200950
Autor:
Karim Chikh, Jacques Orgiazzi, Juliette Abeillon-du Payrat, Véronique Raverot, Pascal Gaucherand, Anne Charrié, Claire Bournaud, O Claris, Patricia Bretones, Nadine Bossard, Françoise Borson-Chazot
Publikováno v:
European Journal of Endocrinology
European Journal of Endocrinology, BioScientifica, 2014, 171 (4), pp.451-60. ⟨10.1530/EJE-14-0254⟩
European Journal of Endocrinology, 2014, 171 (4), pp.451-60. ⟨10.1530/EJE-14-0254⟩
European Journal of Endocrinology, BioScientifica, 2014, 171 (4), pp.451-60. ⟨10.1530/EJE-14-0254⟩
European Journal of Endocrinology, 2014, 171 (4), pp.451-60. ⟨10.1530/EJE-14-0254⟩
ContextHyperthyroidism occurs in 1% of neonates born to mothers with active or past Graves' disease (GD). Current guidelines for the management of GD during pregnancy were based on studies conducted with first-generation thyroid-binding inhibitory im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::520220acdc772995679452632eae24df
https://hal.archives-ouvertes.fr/hal-01859455
https://hal.archives-ouvertes.fr/hal-01859455
Publikováno v:
Annales d'Endocrinologie. 74:270
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3fc3e001af470086cc7aa5d5384e1ca
https://doi.org/10.1016/j.ando.2013.07.108
https://doi.org/10.1016/j.ando.2013.07.108